Krishna Institute of Medical Sciences
KIMSNSE

Krishna Institute of Medical Sciences

₹755.8014.75 (1.99%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
725.15
Today’s high
761.90
52 week low
575.80
52 week high
798.40
Open price
739.60
Previous close
741.05
Live volume
5,41,967
Lower circuit
604.65
Upper circuit
906.95

Fundamentals

Market Cap
₹29,652Cr
ROE
10.74%
P/E Ratio(TTM)
122.49
EPS(TTM)
6.05
P/B Ratio
13.19
Dividend Yield
0.00%
Industry P/E
61.22
Book Value
56.17
Debt to Equity
1.89
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹1,084
+8.12%
Profit (Cr)
₹33.10
-36.22%
03006009001.2k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+35%
3Y CAGR+22%
Profit growthValue
1Y (TTM)-69%
3Y CAGR+6%

About

Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates a chain of multi-specialty hospitals in India.;
CEO/MD
Dr. Abhinay Bollineni
Founded in
2000
NSE symbol
KIMS

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
34.11%
Mutual Funds
27.41%
Retail And Others
16.86%
Foreign Institutions
16.53%
Other Domestic Institutions
5.09%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹8,078.50
+52.50 (0.65%)
L
    H
    1,15,401.5761.8512.7
    ₹1,075.70
    +6.95 (0.65%)
    L
      H
      1,03,825.6573.1710.33
      ₹974.60
      +14.05 (1.46%)
      L
        H
        72,483.5373.917.69
        ₹764.85
        +15.95 (2.13%)
        L
          H
          38,778.7790.839.17
          Livesquawk
          KIMS reported Q4 net profit at ₹425m, down from ₹1.02b YoY. Revenue rose to ₹10.7b vs ₹7.97b YoY; EBITDA margin fell to 19.2%.
          Livesquawk
          Krishna Institute of Medical Sciences' Q4 EBITDA rose to ₹2B from ₹1.98B YoY. Q4 EBITDA margin declined to 19.2% from 24.85% YoY.
          2026
          15
          May
          Quarterly & Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          7
          Nov
          Quarterly Result
          Release date
          6
          Aug
          Quarterly Result
          Release date
          2024

          13
          Sep
          Split
          Ex date
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date13 Sep ‘24
          Record date13 Sep ‘24
          Announcement date28 Jun ‘24

          28
          Jun
          Split
          Announced
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date13 Sep ‘24
          Record date13 Sep ‘24
          Announcement date28 Jun ‘24
          Events calendar
          View upcoming events in other stocks